2023 Q4 Form 10-Q Financial Statement

#000190359623000928 Filed on November 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $34.50K
YoY Change -84.36%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $34.50K
YoY Change -84.36%
Operating Profit $195.6K -$257.9K
YoY Change -2.47%
Interest Expense $4.003K $2.600K
YoY Change 52.21%
% of Operating Profit 2.05%
Other Income/Expense, Net
YoY Change
Pretax Income -$447.5K -$583.4K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$447.5K -$583.4K
YoY Change 47.21% 305.61%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 154.4M shares 315.2M shares 319.4M shares
Diluted Shares Outstanding 315.2M shares 319.4M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $108.3K $6.632K $85.77K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $4.133K $4.133K
Receivables
Other Receivables
Total Short-Term Assets $112.5K $10.77K
YoY Change -78.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $112.5K $10.77K
Total Long-Term Assets $0.00 $0.00
Total Assets $112.5K $10.77K
YoY Change -78.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.574M $1.356M
YoY Change 17.26%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.574M $1.356M
Total Long-Term Liabilities
Total Liabilities $1.574M
YoY Change 17.26%
SHAREHOLDERS EQUITY
Retained Earnings -$4.242M -$3.793M
YoY Change 137.55%
Common Stock $155.5K $323.6K
YoY Change -50.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.462M -$1.345M -$997.3K
YoY Change
Total Liabilities & Shareholders Equity $112.5K $10.77K
YoY Change -78.21%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$447.5K -$583.4K
YoY Change 47.21% 305.61%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001960262
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q3 cik0001960262 Inducement Expense One
InducementExpenseOne
usd
cik0001960262 Inducement Expense One
InducementExpenseOne
usd
CY2022Q2 cik0001960262 Cancellation Of Common Stock
CancellationOfCommonStock
usd
cik0001960262 Stock Issued For Services Related Party
StockIssuedForServicesRelatedParty
usd
cik0001960262 Stock Issued For Option To Acquire Common Stock
StockIssuedForOptionToAcquireCommonStock
usd
cik0001960262 Stock Issued For License Fee
StockIssuedForLicenseFee
usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
usd
cik0001960262 Provision For Obsolete Inventory
ProvisionForObsoleteInventory
usd
cik0001960262 Inducement Expense
InducementExpense
usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Interest Paid
InterestPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
cik0001960262 Conversion Of Notes Payable Into Common Stock
ConversionOfNotesPayableIntoCommonStock
usd
cik0001960262 Stock Repurchased And Returnable In Exchange For Note Payable Related Party
StockRepurchasedAndReturnableInExchangeForNotePayableRelatedParty
usd
cik0001960262 Cancellation Of Common Stock
CancellationOfCommonStock
usd
cik0001960262 Conversion Of Accrued Interest Into Convertible Notes Payable
ConversionOfAccruedInterestIntoConvertibleNotesPayable
usd
cik0001960262 Debt Discount Beneficial Conversion Feature
DebtDiscountBeneficialConversionFeature
usd
cik0001960262 Reclassification From Convertible Notes To Notes Payable
ReclassificationFromConvertibleNotesToNotesPayable
usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-271439
dei Entity Registrant Name
EntityRegistrantName
Ludwig Enterprises, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1133438
dei Entity Address Address Line1
EntityAddressAddressLine1
1749 Victorian Avenue,
dei Entity Address Address Line2
EntityAddressAddressLine2
#C-350
dei Entity Address City Or Town
EntityAddressCityOrTown
Sparks
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89431
dei City Area Code
CityAreaCode
786
dei Local Phone Number
LocalPhoneNumber
235-9026
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154448170 shares
CY2023Q3 us-gaap Cash
Cash
6632 usd
CY2022Q4 us-gaap Cash
Cash
516195 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4133 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
10765 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
516195 usd
CY2023Q3 us-gaap Assets
Assets
10765 usd
CY2022Q4 us-gaap Assets
Assets
516195 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
85950 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
6882 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
630009 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
507136 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
640000 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
828344 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1355959 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1342362 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
7000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
7000000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
7000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
7000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
323570966 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
323570966 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
315188929 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
315188929 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
323570 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
315188 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2287033 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
637577 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3792674 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1785932 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1345194 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826167 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10765 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
516195 usd
CY2023Q3 cik0001960262 Research And Development In Expenses
ResearchAndDevelopmentInExpenses
34498 usd
CY2022Q3 cik0001960262 Research And Development In Expenses
ResearchAndDevelopmentInExpenses
18200 usd
cik0001960262 Research And Development In Expenses
ResearchAndDevelopmentInExpenses
428708 usd
cik0001960262 Research And Development In Expenses
ResearchAndDevelopmentInExpenses
18200 usd
CY2023Q3 cik0001960262 General And Administrative Expenses
GeneralAndAdministrativeExpenses
161072 usd
CY2022Q3 cik0001960262 General And Administrative Expenses
GeneralAndAdministrativeExpenses
182319 usd
cik0001960262 General And Administrative Expenses
GeneralAndAdministrativeExpenses
845328 usd
cik0001960262 General And Administrative Expenses
GeneralAndAdministrativeExpenses
265845 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
195570 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
200519 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1274036 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
284045 usd
CY2023Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-195570 usd
CY2022Q3 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-200519 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1274036 usd
us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-284045 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-61733 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-100823 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-434514 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-284312 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
44475 usd
CY2023Q3 cik0001960262 Inducement Expense One
InducementExpenseOne
-186160 usd
cik0001960262 Inducement Expense One
InducementExpenseOne
-289017 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
4003 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
2630 usd
us-gaap Interest Expense
InterestExpense
9175 usd
us-gaap Interest Expense
InterestExpense
11438 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-251896 usd
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-103453 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-732706 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-251275 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-447466 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-303972 usd
us-gaap Net Income Loss
NetIncomeLoss
-2006742 usd
us-gaap Net Income Loss
NetIncomeLoss
-535320 usd
CY2023Q3 cik0001960262 Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.00
CY2022Q3 cik0001960262 Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.00
cik0001960262 Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.01
cik0001960262 Loss Per Share Basic And Diluted
LossPerShareBasicAndDiluted
-0.00
CY2023Q3 cik0001960262 Weighted Average Number Of Shares Basic And Diluted
WeightedAverageNumberOfSharesBasicAndDiluted
315188929 shares
CY2022Q3 cik0001960262 Weighted Average Number Of Shares Basic And Diluted
WeightedAverageNumberOfSharesBasicAndDiluted
315178059 shares
cik0001960262 Weighted Average Number Of Shares Basic And Diluted
WeightedAverageNumberOfSharesBasicAndDiluted
288008800 shares
cik0001960262 Weighted Average Number Of Shares Basic And Diluted
WeightedAverageNumberOfSharesBasicAndDiluted
313213288 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-826167 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
370000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176400 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-975829 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1255596 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45983 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
795715 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-583447 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-997345 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
36330 usd
CY2023Q3 cik0001960262 Common Stock Issuable In Connection With Extension Of Notes And Convertible Notes Including Inducement Expense
CommonStockIssuableInConnectionWithExtensionOfNotesAndConvertibleNotesIncludingInducementExpense
186160 usd
CY2023Q3 cik0001960262 Stock Repurchased And Returnable In Exchange For Note Payable
StockRepurchasedAndReturnableInExchangeForNotePayable
-122873 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-447466 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1345194 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-57717 usd
CY2022Q1 cik0001960262 Debt Discount Beneficial Conversion Feature
DebtDiscountBeneficialConversionFeature
75000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-87502 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-70219 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
58500 usd
CY2022Q2 cik0001960262 Stock Issued For Services Related Party
StockIssuedForServicesRelatedParty
5200 usd
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-143846 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-149365 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6000 usd
CY2022Q3 cik0001960262 Stock Issued For Asset Purchase
StockIssuedForAssetPurchase
18000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-303972 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-429337 usd
us-gaap Profit Loss
ProfitLoss
-2006742 usd
us-gaap Profit Loss
ProfitLoss
-535320 usd
cik0001960262 Stock Issued For Services
StockIssuedForServices
258713 usd
cik0001960262 Stock Issued For Services
StockIssuedForServices
58500 usd
cik0001960262 Stock Issued For Services Related Party
StockIssuedForServicesRelatedParty
5200 usd
cik0001960262 Stock Issued For Option To Acquire Common Stock
StockIssuedForOptionToAcquireCommonStock
1000 usd
cik0001960262 Stock Issued For License Fee
StockIssuedForLicenseFee
370000 usd
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
18000 usd
cik0001960262 Amortization Of Debt Discount Premium One
AmortizationOfDebtDiscountPremiumOne
434514 usd
cik0001960262 Amortization Of Debt Discount Premium One
AmortizationOfDebtDiscountPremiumOne
284312 usd
cik0001960262 Provision For Obsolete Inventory
ProvisionForObsoleteInventory
46981 usd
cik0001960262 Inducement Expense
InducementExpense
289017 usd
us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
-44475 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4133 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-46981 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
79066 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11438 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-579563 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-201345 usd
us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
6000 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
70000 usd
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
75000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-509563 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-120345 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
516195 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6632 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4655 usd
cik0001960262 Original Issuance Debt Discount
OriginalIssuanceDebtDiscount
30000 usd
cik0001960262 Original Issuance Debt Discount
OriginalIssuanceDebtDiscount
75000 usd
cik0001960262 Conversion Of Notes Payable Into Common Stock
ConversionOfNotesPayableIntoCommonStock
692858 usd
cik0001960262 Stock Repurchased And Returnable In Exchange For Note Payable Related Party
StockRepurchasedAndReturnableInExchangeForNotePayableRelatedParty
122873 usd
cik0001960262 Cancellation Of Common Stock
CancellationOfCommonStock
100 usd
cik0001960262 Conversion Of Accrued Interest Into Convertible Notes Payable
ConversionOfAccruedInterestIntoConvertibleNotesPayable
9473 usd
cik0001960262 Debt Discount Beneficial Conversion Feature
DebtDiscountBeneficialConversionFeature
75000 usd
cik0001960262 Reclassification From Convertible Notes To Notes Payable
ReclassificationFromConvertibleNotesToNotesPayable
429740 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zrU4PSEinNLc" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates during the nine months ended September 30, 2023 and 2022 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"></p><p style="margin-top: 0; margin-bottom: 0; font-weight: bold; text-align: center"></p> <p style="margin-top: 0; margin-bottom: 0; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
0 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34498 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
220600 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
428708 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
265845 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
48620 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
4000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
121397 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
5811 usd
us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
700000000 usd
us-gaap Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
100000000 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
432136 usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 usd
CY2022 cik0001960262 Original Issue Debt Discount
OriginalIssueDebtDiscount
-75000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
507136 usd
cik0001960262 Stock Purchased And Returnable In Exchange For Note Payable
StockPurchasedAndReturnableInExchangeForNotePayable
122873 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
630009 usd
CY2023Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
630009 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
507136 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1307857 usd
CY2022 cik0001960262 Original Issue Debt Discount Convertible Notes Payable
OriginalIssueDebtDiscountConvertibleNotesPayable
-552857 usd
CY2022 cik0001960262 Debt Discount Beneficial Conversion Feature Note
DebtDiscountBeneficialConversionFeatureNote
-75000 usd
CY2022 cik0001960262 Convertible Notes Payable Note Discount
ConvertibleNotesPayableNoteDiscount
138871 usd
CY2022 cik0001960262 Conversion Of Accrued Interest Into Convertible Notes Payable One
ConversionOfAccruedInterestIntoConvertibleNotesPayableOne
9473 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
828344 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000 usd
cik0001960262 Debt Discount Beneficial Conversion Feature Note
DebtDiscountBeneficialConversionFeatureNote
-30000 usd
cik0001960262 Convertible Notes Payable Note Discount
ConvertibleNotesPayableNoteDiscount
434514 usd
cik0001960262 Conversion Of Debt Into Common Stock One
ConversionOfDebtIntoCommonStockOne
-692858 usd
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
640000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
640000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1232857 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
404513 usd
CY2023Q3 cik0001960262 Convertible Notes Payable Net
ConvertibleNotesPayableNet
640000 usd
CY2022Q4 cik0001960262 Convertible Notes Payable Net
ConvertibleNotesPayableNet
828344 usd
cik0001960262 Debtprior To Modification
DebtpriorToModification
151611 usd
cik0001960262 Debtafter Modification
DebtafterModification
107136 usd
cik0001960262 Gain On Debt Extinguishment
GainOnDebtExtinguishment
44475 usd
CY2023Q3 cik0001960262 Fair Value Of Common Stock On Conversion Date
FairValueOfCommonStockOnConversionDate
445714 usd
CY2023Q3 cik0001960262 Fair Value Of Debt Subject To Inducement
FairValueOfDebtSubjectToInducement
342857 usd
CY2023Q3 cik0001960262 Inducement Debt Expense
InducementDebtExpense
102857 usd
CY2023Q3 cik0001960262 Fair Value Of Debt And Common Stock On Extinguishment Date
FairValueOfDebtAndCommonStockOnExtinguishmentDate
1226160 usd
CY2023Q3 cik0001960262 Fair Value Of Debt Subject To Inducement Debt
FairValueOfDebtSubjectToInducementDebt
1040000 usd
CY2023Q3 cik0001960262 Inducement Debt Note Expense
InducementDebtNoteExpense
186160 usd

Files In Submission

Name View Source Status
0001903596-23-000928-index-headers.html Edgar Link pending
0001903596-23-000928-index.html Edgar Link pending
0001903596-23-000928.txt Edgar Link pending
0001903596-23-000928-xbrl.zip Edgar Link pending
cik0001960262-20230930.xsd Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ludg_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cik0001960262-20230930_def.xml Edgar Link unprocessable
cik0001960262-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cik0001960262-20230930_pre.xml Edgar Link unprocessable
ludg_10q_htm.xml Edgar Link completed
cik0001960262-20230930_cal.xml Edgar Link unprocessable